middle.news
Bioxyne Posts Record $21.3m Quarterly Revenue, Secures Aurora Manufacturing Deal
8:56am on Tuesday 21st of April, 2026 AEST
•
Pharmaceuticals
Read Story
Bioxyne Posts Record $21.3m Quarterly Revenue, Secures Aurora Manufacturing Deal
8:56am on Tuesday 21st of April, 2026 AEST
Key Points
Record $21.3m quarterly revenue, up 137% year-on-year
Manufacturing deal signed with Aurora Cannabis for medicinal cannabis oils and vapes
Initial purchase orders secured for GMP psilocybin capsules for treatment-resistant depression
Positive operating cash flow of $1.2m despite working capital investment
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Bioxyne (ASX:BXN)
OPEN ARTICLE